Tevogen Inc. (TVGN) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $426.00; Additional Paid in CapitalUSD $133.18M; Retained Earnings (Accumulated Deficit)USD $-150.87M; Stockholders' Equity Attributable to ParentUSD $-8.89M.
- 2026-03-31: Common Stock, Value, IssuedUSD $417.00; Additional Paid in CapitalUSD $126.46M; Retained Earnings (Accumulated Deficit)USD $-145.11M; Stockholders' Equity Attributable to ParentUSD $-9.84M.
- 2025-12-31: Common Stock, Value, IssuedUSD $402.00; Additional Paid in CapitalUSD $122.63M; Retained Earnings (Accumulated Deficit)USD $-139.66M; Stockholders' Equity Attributable to ParentUSD $-8.23M.
- 2025-09-30: Common Stock, Value, IssuedUSD $19.74K; Additional Paid in CapitalUSD $118.34M; Retained Earnings (Accumulated Deficit)USD $-134.98M; Stockholders' Equity Attributable to ParentUSD $-7.82M.
Tevogen Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Fair Value USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD | Preferred Stock, Value, Issued USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $426.00 | $133.18M | $-150.87M | $-8.89M | 3 month · $3.29M | (m) | 3 month · $2.97M | (m) | (m) |
| 2026-03-31 | $417.00 | $126.46M | $-145.11M | $-9.84M | 3 month · $2.85M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $402.00 | $122.63M | $-139.66M | $-8.23M | 12 month · $16.22M | (m) | (m) | 12 month · $3.50M | (m) |
| 2025-09-30 | $19.74K | $118.34M | $-134.98M | $-7.82M | 3 month · $3.24M | (m) | (m) | 3 month · $1.00M | (m) |
| 2025-06-30 | $19.37K | $110.95M | $-129.26M | $-9.48M | 3 month · $3.24M | (m) | (m) | 3 month · $500.00K | (m) |
| 2025-03-31 | $18.39K | $107.21M | $-123.75M | $-7.72M | 3 month · $7.29M | (m) | (m) | 3 month · $2.00M | (m) |
| 2024-12-31 | $356.00 | $97.91M | $-113.39M | $-6.67M | 12 month · $40.76M | 12 month · $3.00M | (m) | (m) | (m) |
| 2024-09-30 | $17.08K | $90.93M | $-103.94M | $-6.19M | 3 month · $3.33M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $16.88K | $87.61M | $-98.06M | $-7.66M | 3 month · $4.14M | 3 month · $2.80M | (m) | (m) | $2.80M |
| 2024-03-31 | $16.46K | $76.16M | $-88.39M | $-5.80M | 3 month · $26.33M | 3 month · $200.00K | (m) | (m) | (m) |
| 2023-12-31 | $12.00K | $5.22M | $-99.66M | $-94.43M | (m) | (m) | (m) | 12 month · $275.31K | (m) |
| 2023-09-30 | (m) | (m) | $-16.16M | $-90.80M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | $-15.55M | $-86.89M | (m) | (m) | (m) | 3 month · $275.31K | (m) |
| 2023-03-31 | (m) | (m) | $-15.33M | $-64.71M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $-14.78M | $-33.95M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | $-14.66M | $-14.66M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | $-14.05M | $-14.05M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | $-14.26M | $-14.25M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $-14.23M | $-14.23M | (m) | 8 month · $-588.25K 8 month · $-588.25K | 8 month · $11.82M 8 month · $11.82M | (m) | (m) |
| 2021-09-30 | (m) | $23.80K | $-11.41K | $13.59K | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | $13.70K | (m) | (m) | (m) | (m) | (m) |
| 2021-04-30 | (m) | (m) | (m) | $18.02K | (m) | (m) | (m) | (m) | (m) |
| 2021-04-21 | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2021-04-20 | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |